Tweetovi

Blokirali ste korisnika/cu @stacyamityfeld

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @stacyamityfeld

  1. proslijedio/la je Tweet
    3. velj

    Thank you ⁦⁩ and ⁦⁩ for the opportunity to be on one of my favorite podcasts: Tech Tonics. I talk about my work often but this is probably the first time I’m sharing my journey as an immigrant.

    Poništi
  2. 30. sij

    “Women can’t start companies if they can’t get funding, and VCs tend to be a who-you-know business, so putting more women on boards should help create a virtuous cycle of entrepreneurship.” ⁦⁩ ⁦

    Poništi
  3. proslijedio/la je Tweet
    24. sij
    Poništi
  4. proslijedio/la je Tweet
    24. sij

    Creating a diverse & inclusive industry where everyone thrives is essential to deliver innovative new medicines & healthcare solutions for patients globally. We at & are proud co-founders, sponsors & members of - such an important 🇦🇺 initiative!

    Poništi
  5. proslijedio/la je Tweet
    23. sij

    Firsthand experiences in his personal and professional life led our founder to start Carrot. 4 years later, we’ve teamed up with on our mission to help millions quit smoking with . Learn more about our partnership:

    Poništi
  6. 21. sij

    “When members of diverse teams see things in a variety of ways, they are poised to recognize new and different market opportunities, and they can better appreciate unmet market needs.”

    Poništi
  7. 17. sij

    Mission-driven founder stories are at the soul of successful companies. Dig into this story of founder and the mission to rethink how people quit smoking:

    Poništi
  8. proslijedio/la je Tweet

    The first time smoked, he was 10 & in the backseat of his aunt’s Chevy Nova. Decades later, he established a digital health company to empower people to quit. See how we’re teaming up w/ in the quest to ‘cure’ smoking:

    Poništi
  9. proslijedio/la je Tweet
    15. sij

    As the healthcare investment world converges on , 's addresses common misconceptions in biotech, from the risks posed by FDA approval and reimbursement to the best ways to build enduring biotech companies

    Poništi
  10. proslijedio/la je Tweet
    16. sij

    First, it was "health." Then, "OnlineHealth." Then, "eHealth." Then, "DigitalHealth." Someday soon, it will just be "health" again.

    Poništi
  11. proslijedio/la je Tweet

    Advances in have piqued investor interest. Today at the , , Head, JJI, West North America, Australia, & New Zealand discusses how innovators can leverage this interest & maintain the momentum to speed breakthroughs for women.

    Poništi
  12. 15. sij

    On ⁦⁩: “Health info-seekers are hungry for answers and often on a personal mission to become as educated as their healthcare providers. Become their one-stop shop by putting more thought and effort into disease education.”

    Poništi
  13. proslijedio/la je Tweet
    15. sij

    127 women in venture capital together at making progress!

    Poništi
  14. 15. sij

    trends: “Electrons will replace molecules...this is a paradigm shift”

    Poništi
  15. proslijedio/la je Tweet
    14. sij

    Digital TX (evidence-based therapeutic interventions to prevent, manage, or treat disease) IMO are overbashed and underfunded because categorized w/in the overhyped "digital health" area ( includes Goop-ey wellness stuff). Groups like attempting to address

    Poništi
  16. proslijedio/la je Tweet
    14. sij

    We're thrilled to see our groundbreaking smoking cessation solution mentioned here.

    Poništi
  17. proslijedio/la je Tweet
    14. sij

    2019 year in review! deployed >$500M in capital, made 40 new/follow-on investments. Hear from our new head of Chris Picariello and learn about some of our investments including

    Poništi
  18. 14. sij

    Congrats on continuing to drive impact in digital health.

    Poništi
  19. proslijedio/la je Tweet
    13. sij
    Poništi
  20. proslijedio/la je Tweet

    Will 2020 be the year to invest in the 🧠? This morning at ’s State of the Industry Roundtable hear from , Vice President & Global Lead, Neuroscience External Innovation, as he shares insights on what’s to come for neurotherapeutics in the 2020s.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·